Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS
· Delayed Price · Currency is USD
28.19
-0.68 (-2.36%)
Apr 28, 2025, 4:00 PM EDT
Chugai Pharmaceutical Revenue
Chugai Pharmaceutical had revenue of 288.46B JPY in the quarter ending March 31, 2025, with 21.74% growth. This brings the company's revenue in the last twelve months to 1.22T, up 17.96% year-over-year. In the year 2024, Chugai Pharmaceutical had annual revenue of 1.17T with 5.33% growth.
Revenue (ttm)
1,222.12B JPY
Revenue Growth
+17.96%
P/S Ratio
11.33
Revenue / Employee
243.16M JPY
Employees
5,026
Market Cap
92.46B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,170.61B | 59.24B | 5.33% |
| Dec 31, 2023 | 1,111.37B | -148.58B | -11.79% |
| Dec 31, 2022 | 1,259.95B | 260.19B | 26.02% |
| Dec 31, 2021 | 999.76B | 212.81B | 27.04% |
| Dec 31, 2020 | 786.95B | 100.76B | 14.68% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |
Chugai Pharmaceutical News
- 18 days ago - Japanese Stocks Close Lower Amid Global Trade Tensions - Barron's
- 3 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Chugai Pharmaceutical Co., Ltd. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Full Year 2024 Chugai Pharmaceutical Co Ltd Earnings Presentation Transcript - GuruFocus
- 3 months ago - Chugai Pharmaceutical GAAP EPS of $253.36, revenue of $1.17B - Seeking Alpha
- 6 months ago - Chugai Pharmaceutical Co., Ltd. 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market - Benzinga